✦ LIBER ✦

The tolerability, pharmacokinetics and effect on plasma cholesterol of 447C88, an ACAT inhibitor with low bioavailability, in healthy volunteers

✍ Scribed by R.W. Peck; R. Wiggs; J. Posner

Book ID: 118325305
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 307 KB
Volume: 109
Category: Article
ISSN: 0021-9150
DOI: 10.1016/0021-9150(94)93634-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The tolerability, pharmacokinetics and l

The tolerability, pharmacokinetics and lack of effect on plasma cholesterol of 447C88, an AcylCoA:Cholesterol Acyl Transferase (ACAT) inhibitor with low bioavailability, in healthy volunteers

✍ R. W. Peck; R. Wiggs; J. Posner 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 657 KB

2 dimethylpropyl) phenyl)ethyl)phenyl)urea) is an inhibitor of human microsomal AcylCoA: Cholesterol acyltransferase (ACAT) with an ICs0 of 10.2 rig' m1-1 (23 nM). It is poorly absorbed but 5 mg. kg-1-daycompletely abolishes the rise in plasma cholesterol in cholesterol-fed rats. In this study, tw

Effect of the ACAT inhibitor CI-976 on p

Effect of the ACAT inhibitor CI-976 on plasma cholesterol concentrations and distribution in hamsters fed zero- and low-cholesterol diets

✍ Brian R. Krause; Richard F. Bousley; Karen A. Kieft; Richard L. Stanfield 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 724 KB

The overall objective of the present study was to determine if the ACAT inhibitor CI-976 can lower plasma cholesterol in hamsters fed zero or low, "human-like" levels of cholesterol. With a purified diet containing zero dietary cholesterol, CI-976 significantly lowered VLDL cholesterol (VLDL-C), but